About SYGNIS
SYGNIS is a company based in Madrid (Spain) founded in 1997. It operates as a B2B. SYGNIS has completed 4 acquisitions, including CBS Scientific, Expedeon and Innova Biosciences. SYGNIS operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Latest Funding Round
$2.38 M (USD), Debt – Conventional
May 09, 2018
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
CBS Scientific
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SYGNIS
- Total Funding Total Funding
- Total Rounds 11
- Last Round Debt – Conventional — $2.4M
-
First Round
First Round
(06 Nov 2008)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Post-IPO - SYGNIS | Valuation |
investors |
|
| May, 2018 | Amount | Debt – Conventional - SYGNIS | Valuation |
investors |
|
| Mar, 2018 | Amount | Post-IPO - SYGNIS | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by SYGNIS
SYGNIS has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include CBS Scientific, Expedeon and Innova Biosciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Reagents and kits for protein-based research are developed and supplied.
|
2003 | ||||
|
Antibody labeling and bioconjugation kits are developed and marketed.
|
2002 | ||||
|
Specializes in immunoassay technology
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SYGNIS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sygnis Comparisons
Competitors of SYGNIS
SYGNIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Proteins, antibodies, and molecular tools are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sygnis
Frequently Asked Questions about SYGNIS
When was SYGNIS founded?
SYGNIS was founded in 1997 and raised its 1st funding round 11 years after it was founded.
Where is SYGNIS located?
SYGNIS is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
What is the annual revenue of SYGNIS?
Annual revenue of SYGNIS is $403.09K as on Mar 31, 2022.
What does SYGNIS do?
SYGNIS, based in Madrid, focuses on providing healthcare solutions, advancing biotech innovations, life sciences, and reagents and supplies. SYGNIS provides molecular biology reagents for research and laboratory applications. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of SYGNIS?
SYGNIS's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
How many acquisitions has SYGNIS made?
SYGNIS has made 4 acquisitions, including CBS Scientific, Expedeon, and Innova Biosciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.